Europe PMC

This website requires cookies, and the limited processing of your personal data in order to function. By using the site you are agreeing to this as outlined in our privacy notice and cookie policy.

Abstract 


The host restricts dissemination of invasive enteric pathogens, such as non-typhoidal Salmonella serovars, by mounting acute inflammatory responses characterized by the recruitment of neutrophils. However, some enteric pathogens, such as Salmonella enterica serovar Typhi (S. typhi), can bypass these defenses and cause an invasive bloodstream infection known as typhoid fever. Recent studies on virulence mechanisms of S. typhi suggest that tight regulation of virulence gene expression during the transition from the intestinal lumen into the intestinal mucosa enables this pathogen to evade detection by the innate immune system, thereby penetrating defenses that prevent bacterial dissemination. This example illustrates how the outcome of host pathogen interaction at the intestinal mucosal interface can alter the clinical presentation and dictate the disease outcome.

Free full text 


Logo of gmicLink to Publisher's site
Gut Microbes. 2012 Mar 1; 3(2): 88–92.
PMCID: PMC3370952
PMID: 22156762

Typhoid fever

“You can’t hit what you can’t see”

Abstract

The host restricts dissemination of invasive enteric pathogens, such as non-typhoidal Salmonella serovars, by mounting acute inflammatory responses characterized by the recruitment of neutrophils. However, some enteric pathogens, such as Salmonella enterica serovar Typhi (S. typhi), can bypass these defenses and cause an invasive bloodstream infection known as typhoid fever. Recent studies on virulence mechanisms of S. typhi suggest that tight regulation of virulence gene expression during the transition from the intestinal lumen into the intestinal mucosa enables this pathogen to evade detection by the innate immune system, thereby penetrating defenses that prevent bacterial dissemination. This example illustrates how the outcome of host pathogen interaction at the intestinal mucosal interface can alter the clinical presentation and dictate the disease outcome.

Keywords: diarrhea, gastroenteritis, inflammation, Salmonella, typhoid fever

In immunocompetent individuals non-typhoidal Salmonella serovars are associated with gastroenteritis, a localized infection of the terminal ileum, colon and mesenteric lymph nodes.1 Upon ingestion, non-typhoidal Salmonella serovars use flagella-mediated motility and the invasion-associated type III secretion system (T3SS-1) to enter the ileal and colonic mucosa.2,3 Subsequently, a second type III secretion system (T3SS-2) is deployed to mediate survival in tissue macrophages.4 The presence of bacteria in tissue can be sensed by the host innate immune surveillance system through detection of conserved molecular patterns.5 For example, bacterial flagellin is a conserved molecular pattern recognized by Toll-like receptor 5 (TLR5)6 the lipid A moiety of lipopolysaccharide (LPS) is recognized by the TLR4/MD2/CD14 receptor complex7 and the O-antigen moiety of LPS is recognized by complement (Fig. 1), which involves covalent attachment of complement component 3 fragment b (C3b) by an ester bond formed with free hydroxyl-groups in LPS sugar moieties.8 In addition, the host can gauge the pathogenic potential of microbes by detecting pathogen-induced processes.9 A pathogen-induced process that marks non-typhoidal Salmonella serovars for detection by the host is the deployment of T3SS-1, sensed through NLRC4 (nucleotide-binding oligomerization domain-like receptor family caspase-associated recruitment domain-containing protein 4).10-12

An external file that holds a picture, illustration, etc.
Object name is gmic-3-88-g1.jpg

Figure 1. Detection of S. typhimurium by the innate immune system results in neutrophil recruitment. Complement, TLR5 and TLR4/MD2/CD14 detect conserved molecular patterns of S. typhimurium, including LPS and flagella. A pathogen-induced process detected by the host innate immune system is the deployment of T3SS-1, which is sensed through NLRC4. Signals generated by activation of complement, TLR5, TLR4/MD2/CD14 and NLRC4 cooperate in orchestrating neutrophil recruitment.

The detection of conserved molecular patterns and pathogen-induced processes by the innate immune system induces pro-inflammatory responses that culminate in the recruitment of neutrophils, the pathological hallmark of gastroenteritis (reviewed in ref. 13). Macrophages are the preferred intracellular niche of non-typhoidal Salmonella serovars and might serve as a vehicle for their dissemination. Intracellular survival in macrophages shelters non-typhoidal Salmonella serovars from neutrophil attack. However, macrophages can detect the vacuolar pathogen through NLRC4 and react by releasing non-typhoidal Salmonella serovars through pyroptosis (reviewed in ref. 14), a process that exposes the microbe to neutrophils.15 Clearance of bacteria from systemic sites makes neutrophils an effective defense against disseminated bacterial infection as illustrated by the fact that neutropenia is a risk factor for developing bloodstream infections with non-typhoidal Salmonella serovars.16,17

Similar to non-typhoidal Salmonella serovars, S. typhi employs its flagella and T3SS-1 to invade the intestinal epithelium,18,19 followed by T3SS-2-mediated survival inside macrophages.20 Akin to non-typhoidal Salmonella serovars, purified S. typhi flagellin signals through TLR5,21 the lipid A moiety of purified S. typhi LPS is a potent TLR4/MD2/CD14 agonist,22 the O-antigen of purified S. typhi LPS activates complement23 and macrophages detect the deployment of the S. typhi T3SS-1 as pathogen-induced process in vitro24 (Fig. 1). However, in humans S. typhi is associated with typhoid fever, which differs dramatically in its clinical presentation from gastroenteritis caused by non-typhoidal Salmonella serovars (reviewed in ref. 25). While rapid recruitment of neutrophils leads to symptoms of gastroenteritis within 24 h after ingestion of non-typhoidal Salmonella serovars,26 S. typhi does not evoke overt responses during the initial invasion of the intestinal mucosa, as indicated by an average incubation period of two weeks.27 Although S. typhi causes intestinal inflammation, the inflammatory infiltrates are dominated by mononuclear cells and neutrophils are scarce.28-32 Finally, S. typhi causes a disseminated bloodstream infection in immunocompetent individuals, while non-typhoidal Salmonella serovars are associated with a localized gastroenteritis. These clinical observations raise the question of how pathogens that are so similar in their basic repertoire of virulence factors can cause so different host responses and disease manifestations in humans. Surprisingly, inconspicuous changes in the control of virulence gene expression in S. typhi might hold the answer to this question.

A first clue on how gene regulation in S. typhi differs from that in non-typhoidal Salmonella serovars came from studies by Eleanor Metcalf and coworkers on invasion of epithelial cell lines. This work revealed that, unlike non-typhoidal Salmonella serovars, S. typhi needs to be grown under conditions of high-osmolarity (300 mM NaCl) for optimal invasion33 and maximum expression of T3SS-1 genes.34 The second clue was provided by the observation that S. typhi grown at low-osmolarity is poorly invasive, but entry into epithelial cells is markedly increased in strains lacking expression of the virulence (Vi) capsular polysaccharide, also known as Vi-antigen.35 Production of the Vi-antigen is encoded by the viaB (Vi-antigen B) locus, a 14 kb DNA region on the S. typhi chromosome that is absent from the genomes of non-typhoidal Salmonella serovars associated with human gastroenteritis.36,37 Expression of the Vi-antigen at low-osmolarity correlates with reduced secretion of flagellin and impaired invasiveness. In contrast, growth of S. typhi at high-osmolarity conditions suppresses Vi-antigen expression, which is accompanied by increased invasiveness and elevated flagellin secretion.38,39 It turns out that the first gene within the viaB locus, tviA, encodes the regulatory protein responsible for these phenotypic changes.40

The tviA gene is not expressed under high-osmolarity conditions, but the EnvZ/OmpR two-component regulatory system induces tviA expression under conditions of low-osmolarity.40,41 TviA forms heterodimers with RcsB, the response regulator of the RcsBCD phosphorelay system, to activate expression of genes in the viaB locus, which encode proteins involved in the Vi-antigen biosynthesis (tviBCDE) and Vi-antigen export (vexABCDE).37,42 Furthermore, TviA in conjunction with RcsB represses expression of the flhDC genes (Fig. 2).40,43 FlhDC is the master regulator of flagellin gene expression.44 One FlhDC-regulated gene, fliZ, encodes a regulatory protein that induces expression of the hilD gene, encoding an activator of the hilA gene.45,46 Finally, HilA positively regulates T3SS-1 gene expression.47,48 Through this mechanism, TviA suppresses invasion and flagella production, while activating Vi-antigen expression at low-osmolarity conditions (Fig. 2).40 But how can this unassuming change in virulence gene expression alter the outcome of host pathogen interaction?

An external file that holds a picture, illustration, etc.
Object name is gmic-3-88-g2.jpg

Figure 2. TviA-mediated gene regulation conceals conserved molecular patterns and pathogen-induced processes during S. typhi infection. Expression of TviA is induced at tissue osmolarity by the OmpR/EnvZ two-component system. TviA in conjunction with RcsB activates expression of the tviBCDEvexABCDE operon and represses expression of the flhDC operon. As a result, S. typhi expresses the Vi-antigen while suppressing flagella and T3SS-1 expression when entering the intestinal mucosa. The Vi-antigen interferes with the detection of LPS as a conserved molecular pattern. Thus, TviA-mediated gene regulation prevents detection of a pathogen-induced process (i.e., the deployment of T3SS-1) and detection of conserved molecular patterns (i.e., LPS and flagella) by the innate immune surveillance system in the intestinal mucosa.

Full suppression of tviA expression occurs at conditions that resemble the osmolarity encountered in the intestinal lumen.49 This regulation ensures that S. typhi is motile and invasive as it approaches the mucosal surface. However, upon invasion of the intestinal epithelium, S. typhi is exposed to conditions of lower osmolarity, which results in a rapid induction of TviA expression.49 In turn, TviA in conjunction with RcsB induces expression of the Vi-antigen, while repressing flagella and T3SS-1 expression as the pathogen transits through the epithelium (Fig. 2).49,50 Once S. typhi emerges in the lamina propria, several pathogen-induced processes and conserved molecular patterns are no longer detectable by the innate immune surveillance system.

Specifically, TviA/RcsB turns off expression of flagella, a conserved molecular pattern whose detection by TLR5 expressed on the basolateral surface of epithelial cells serves as an indicator of microbial translocation from the gut.43 When TviA expression in S. typhi is induced in vitro by inactivating rpoS, a gene encoding a negative regulator of tviA,51 macrophages exhibit a reduced ability to release intracellular bacteria through pyroptosis.52 These data suggest that the ability of macrophages to detect a pathogen-induced process of S. typhi is impaired, presumably because TviA-regulation suppresses T3SS-1 expression. Finally, expression of the Vi-antigen by S. typhi prevents complement activation through the alternative pathway,53,54 most likely because this capsular polysaccharide does not contain free hydroxyl groups that could form ester bonds with C3b,55 a process necessary for formation of C3 convertase on the bacterial surface. Complement activation leads to the generation of the anaphylatoxins C3a and C5a, two potent enhancers of cytokine responses elicited by endotoxin (lipid A) (reviewed in ref. 56). Thus, reduced complement activation might explain the apparent inhibition of TLR4/CD14/MD2 signaling by the Vi-antigen.57-60 In summary, when S. typhi enters the intestinal mucosa, TviA-regulation helps the microbe to conceal pathogen-induced processes and conserved molecular patterns (Fig. 1) from its host. Through this “stealth” mechanism, S. typhi eludes detection by the innate immune system, a “you can’t hit what you can’t see*”-strategy that makes it difficult for the host to contain the dissemination of the intruding microbe.

By evading detection by the innate immune system, the viaB locus impairs neutrophil recruitment in the intestinal mucosa,61,62 which helps explain the scarcity of neutrophils in intestinal infiltrates28-32 and the long incubation period of typhoid fever.27 A viaB-mediated inhibition of pyroptosis might also reduce exposure of S. typhi to neutrophil attack.52 Furthermore, inhibition of C3b deposition on the bacterial surface prevents phagocytosis of S. typhi through complement receptor (CR) 3,53,54 a process coupled to a respiratory burst in neutrophils.8 Through this mechanism, S. typhi prevents phagocytosis and the generation of a respiratory burst when it encounters neutrophils,63-65 a cell type crucial for preventing dissemination of non-typhoidal Salmonella serovars in humans, as indicated by the increased risk of neutropenic individuals to develop bloodstream infections.16,17 Finally, TviA-mediated repression of flagella expression increases bacterial dissemination in an animal model, presumably because detection of this conserved molecular pattern by the innate immune system helps to orchestrate host responses that enhance bacterial clearance from systemic sites and/or prevent bacterial dissemination49 (Fig. 1). Collectively, these mechanisms help explain why S. typhi slips past the host’s defenses to cause an invasive bloodstream infection, even in immunocompetent individuals.

The picture emerging from these studies is that subtle changes in the regulation of virulence gene expression can influence the outcome of host pathogen interaction in the intestinal mucosa. Common approaches for studying innate immunity, such as stimulating host cells with purified conserved molecular patterns, cannot model such interactions accurately, which is one of the reasons why TviA-mediated innate immune evasion has eluded us until recently. Furthermore, studies on the interaction of S. typhi with tissue culture cells can be misleading, unless care is taken that bacteria are cultured under conditions that mimic gene expression in vivo. Although TviA-mediated innate immune evasion is easily overlooked, its influence on the outcome of host pathogen interaction is profound, as vividly illustrated by the different clinical presentations of typhoid fever and gastroenteritis.

Acknowledgments

Work in A.J.B.’s laboratory is supported by Public Health Service Grants AI040124, AI044170, AI076246, AI088122 and AI096528.

Footnotes

*Walter Johnson

Previously published online: www.landesbioscience.com/journals/gutmicrobes/article/18602

References

1. Rabsch W, Tschape H, Baumler AJ. Non-typhoidal salmonellosis: emerging problems. Microbes Infect. 2001;3:237–47. 10.1016/S1286-4579(01)01375-2. [Abstract] [CrossRef] [Google Scholar]
2. Galán JE, Curtiss R., III Cloning and molecular characterization of genes whose products allow Salmonella typhimurium to penetrate tissue culture cells. Proc Natl Acad Sci USA. 1989;86:6383–7. 10.1073/pnas.86.16.6383. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
3. Khoramian-Falsafi T, Harayama S, Kutsukake K, Pechere JC. Effect of motility and chemotaxis on the invasion of Salmonella typhimurium into HeLa cells. Microb Pathog. 1990;9:47–53. 10.1016/0882-4010(90)90039-S. [Abstract] [CrossRef] [Google Scholar]
4. Ochman H, Soncini FC, Solomon F, Groisman EA. Identification of a pathogenicity island for Salmonella survival in host cells. Proc Natl Acad Sci USA. 1996;93:7800–4. 10.1073/pnas.93.15.7800. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
5. Janeway CA., Jr. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol. 1989;54:1–13. [Abstract] [Google Scholar]
6. Gewirtz AT, Navas TA, Lyons S, Godowski PJ, Madara JL. Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. J Immunol. 2001;167:1882–5. [Abstract] [Google Scholar]
7. Vazquez-Torres A, Vallance BA, Bergman MA, Finlay BB, Cookson BT, Jones-Carson J, et al. Toll-like receptor 4 dependence of innate and adaptive immunity to Salmonella: importance of the Kupffer cell network. J Immunol. 2004;172:6202–8. [Abstract] [Google Scholar]
8. Joiner KA, Ganz T, Albert J, Rotrosen D. The opsonizing ligand on Salmonella typhimurium influences incorporation of specific, but not azurophil, granule constituents into neutrophil phagosomes. J Cell Biol. 1989;109:2771–82. 10.1083/jcb.109.6.2771. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
9. Vance RE, Isberg RR, Portnoy DA. Patterns of pathogenesis: discrimination of pathogenic and nonpathogenic microbes by the innate immune system. Cell Host Microbe. 2009;6:10–21. 10.1016/j.chom.2009.06.007. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
10. Miao EA, Alpuche-Aranda CM, Dors M, Clark AE, Bader MW, Miller SI, et al. Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1beta via Ipaf. Nat Immunol. 2006;7:569–75. 10.1038/ni1344. [Abstract] [CrossRef] [Google Scholar]
11. Franchi L, Amer A, Body-Malapel M, Kanneganti TD, Ozoren N, Jagirdar R, et al. Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1beta in salmonella-infected macrophages. Nat Immunol. 2006;7:576–82. 10.1038/ni1346. [Abstract] [CrossRef] [Google Scholar]
12. Miao EA, Mao DP, Yudkovsky N, Bonneau R, Lorang CG, Warren SE, et al. Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome. Proc Natl Acad Sci USA. 2010;107:3076–80. 10.1073/pnas.0913087107. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
13. Santos RL, Raffatellu M, Bevins CL, Adams LG, Tukel C, Tsolis RM, et al. Life in the inflamed intestine, Salmonella style. Trends Microbiol. 2009;17:498–506. 10.1016/j.tim.2009.08.008. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
14. Bergsbaken T, Fink SL, Cookson BT. Pyroptosis: host cell death and inflammation. Nat Rev Microbiol. 2009;7:99–109. 10.1038/nrmicro2070. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
15. Miao EA, Leaf IA, Treuting PM, Mao DP, Dors M, Sarkar A, et al. Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria. Nat Immunol. 2010;11:1136–42. 10.1038/ni.1960. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
16. Noriega LM, Van der Auwera P, Daneau D, Meunier F, Aoun M. Salmonella infections in a cancer center. Support Care Cancer. 1994;2:116–22. 10.1007/BF00572093. [Abstract] [CrossRef] [Google Scholar]
17. Tumbarello M, Tacconelli E, Caponera S, Cauda R, Ortona L. The impact of bacteraemia on HIV infection. Nine years experience in a large Italian university hospital. J Infect. 1995;31:123–31. 10.1016/S0163-4453(95)92110-9. [Abstract] [CrossRef] [Google Scholar]
18. Liu SL, Ezaki T, Miura H, Matsui K, Yabuuchi E. Intact motility as a Salmonella typhi invasion-related factor. Infect Immun. 1988;56:1967–73. [Europe PMC free article] [Abstract] [Google Scholar]
19. Elsinghorst EA, Baron LS, Kopecko DJ. Penetration of human intestinal epithelial cells by Salmonella: molecular cloning and expression of Salmonella typhi invasion determinants in Escherichia coli. Proc Natl Acad Sci USA. 1989;86:5173–7. 10.1073/pnas.86.13.5173. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
20. Forest CG, Ferraro E, Sabbagh SC, Daigle F. Intracellular survival of Salmonella enterica serovar Typhi in human macrophages is independent of Salmonella pathogenicity island (SPI)-2. Microbiology. 2010;156:3689–98. 10.1099/mic.0.041624-0. [Abstract] [CrossRef] [Google Scholar]
21. Wyant TL, Tanner MK, Sztein MB. Salmonella typhi flagella are potent inducers of proinflammatory cytokine secretion by human monocytes. Infect Immun. 1999;67:3619–24. [Europe PMC free article] [Abstract] [Google Scholar]
22. Bignold LP, Rogers SD, Siaw TM, Bahnisch J. Inhibition of chemotaxis of neutrophil leukocytes to interleukin-8 by endotoxins of various bacteria. Infect Immun. 1991;59:4255–8. [Europe PMC free article] [Abstract] [Google Scholar]
23. Gewurz H, Mergenhagen SE, Nowotny A, Phillips JK. Interactions of the complement system with native and chemically modified endotoxins. J Bacteriol. 1968;95:397–405. [Europe PMC free article] [Abstract] [Google Scholar]
24. Hersh D, Monack DM, Smith MR, Ghori N, Falkow S, Zychlinsky A. The Salmonella invasin SipB induces macrophage apoptosis by binding to caspase-1. Proc Natl Acad Sci USA. 1999;96:2396–401. 10.1073/pnas.96.5.2396. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
25. Tsolis RM, Young GM, Solnick JV, Baumler AJ. From bench to bedside: stealth of enteroinvasive pathogens. Nat Rev Microbiol. 2008;6:883–92. 10.1038/nrmicro2012. [Abstract] [CrossRef] [Google Scholar]
26. Glynn JR, Palmer SR. Incubation period, severity of disease, and infecting dose: evidence from a Salmonella outbreak. Am J Epidemiol. 1992;136:1369–77. [Abstract] [Google Scholar]
27. Olsen SJ, Bleasdale SC, Magnano AR, Landrigan C, Holland BH, Tauxe RV, et al. Outbreaks of typhoid fever in the United States, 1960-99. Epidemiol Infect. 2003;130:13–21. 10.1017/S0950268802007598. [Abstract] [CrossRef] [Google Scholar]
28. Mallory FB. A histological study of typhoid fever. J Exp Med. 1898;3:611–38. 10.1084/jem.3.6.611. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
29. Sprinz H, Gangarosa EJ, Williams M, Hornick RB, Woodward TE. Histopathology of the upper small intestines in typhoid fever. Biopsy study of experimental disease in man. Am J Dig Dis. 1966;11:615–24. 10.1007/BF02233509. [Abstract] [CrossRef] [Google Scholar]
30. Hornick RB, Greisman SE, Woodward TE, DuPont HL, Dawkins AT, Snyder MJ. Typhoid fever: pathogenesis and immunologic control (second of two parts) N Engl J Med. 1970;283:739–46. 10.1056/NEJM197010012831406. [Abstract] [CrossRef] [Google Scholar]
31. Mukawi TJ. Histopathological study of typhoid perforation of the small intestines. Southeast Asian J Trop Med Public Health. 1978;9:252–5. [Abstract] [Google Scholar]
32. Kraus MD, Amatya B, Kimula Y. Histopathology of typhoid enteritis: morphologic and immunophenotypic findings. Mod Pathol. 1999;12:949–55. [Abstract] [Google Scholar]
33. Tartera C, Metcalf ES. Osmolarity and growth phase overlap in regulation of Salmonella typhi adherence to and invasion of human intestinal cells. Infect Immun. 1993;61:3084–9. [Europe PMC free article] [Abstract] [Google Scholar]
34. Leclerc GJ, Tartera C, Metcalf ES. Environmental regulation of Salmonella typhi invasion-defective mutants. Infect Immun. 1998;66:682–91. [Europe PMC free article] [Abstract] [Google Scholar]
35. Miyake M, Zhao L, Ezaki T, Hirose K, Khan AQ, Kawamura Y, et al. Vi-deficient and nonfimbriated mutants of Salmonella typhi agglutinate human blood type antigens and are hyperinvasive. FEMS Microbiol Lett. 1998;161:75–82. 10.1111/j.1574-6968.1998.tb12931.x. [Abstract] [CrossRef] [Google Scholar]
36. Johnson EM, Baron LS. Genetic transfer of the Vi antigen from Salmonella typhosa to Escherichia coli. J Bacteriol. 1969;99:358–9. [Europe PMC free article] [Abstract] [Google Scholar]
37. Virlogeux I, Waxin H, Ecobichon C, Popoff MY. Role of the viaB locus in synthesis, transport and expression of Salmonella typhi Vi antigen. Microbiology. 1995;141:3039–47. 10.1099/13500872-141-12-3039. [Abstract] [CrossRef] [Google Scholar]
38. Arricau N, Hermant D, Waxin H, Ecobichon C, Duffey PS, Popoff MY. The RcsB-RcsC regulatory system of Salmonella typhi differentially modulates the expression of invasion proteins, flagellin and Vi antigen in response to osmolarity. Mol Microbiol. 1998;29:835–50. 10.1046/j.1365-2958.1998.00976.x. [Abstract] [CrossRef] [Google Scholar]
39. Zhao L, Ezak T, Li ZY, Kawamura Y, Hirose K, Watanabe H. Vi-Suppressed wild strain Salmonella typhi cultured in high osmolarity is hyperinvasive toward epithelial cells and destructive of Peyer's patches. Microbiol Immunol. 2001;45:149–58. [Abstract] [Google Scholar]
40. Winter SE, Winter MG, Thiennimitr P, Gerriets VA, Nuccio SP, Russmann H, et al. The TviA auxiliary protein renders the Salmonella enterica serotype Typhi RcsB regulon responsive to changes in osmolarity. Mol Microbiol. 2009;74:175–93. 10.1111/j.1365-2958.2009.06859.x. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
41. Pickard D, Li J, Roberts M, Maskell D, Hone D, Levine M, et al. Characterization of defined ompR mutants of Salmonella typhi: ompR is involved in the regulation of Vi polysaccharide expression. Infect Immun. 1994;62:3984–93. [Europe PMC free article] [Abstract] [Google Scholar]
42. Virlogeux I, Waxin H, Ecobichon C, Lee JO, Popoff MY. Characterization of the rcsA and rcsB genes from Salmonella typhi: rcsB through tviA is involved in regulation of Vi antigen synthesis. J Bacteriol. 1996;178:1691–8. [Europe PMC free article] [Abstract] [Google Scholar]
43. Winter SE, Raffatellu M, Wilson RP, Russmann H, Baumler AJ. The Salmonella enterica serotype Typhi regulator TviA reduces interleukin-8 production in intestinal epithelial cells by repressing flagellin secretion. Cell Microbiol. 2008;10:247–61. [Abstract] [Google Scholar]
44. Kutsukake K, Ohya Y, Iino T. Transcriptional analysis of the flagellar regulon of Salmonella typhimurium. J Bacteriol. 1990;172:741–7. [Europe PMC free article] [Abstract] [Google Scholar]
45. Kage H, Takaya A, Ohya M, Yamamoto T. Coordinated regulation of expression of Salmonella pathogenicity island 1 and flagellar type III secretion systems by ATP-dependent ClpXP protease. J Bacteriol. 2008;190:2470–8. 10.1128/JB.01385-07. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
46. Lin D, Rao CV, Slauch JM. The Salmonella SPI1 type three secretion system responds to periplasmic disulfide bond status via the flagellar apparatus and the RcsCDB system. J Bacteriol. 2008;190:87–97. 10.1128/JB.01323-07. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
47. Lee CA, Jones BD, Falkow S. Identification of a Salmonella typhimurium invasion locus by selection for hyperinvasive mutants. Proc Natl Acad Sci USA. 1992;89:1847–51. 10.1073/pnas.89.5.1847. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
48. Bajaj V, Hwang C, Lee CA. hilA is a novel ompR/toxR family member that activates the expression of Salmonella typhimurium invasion genes. Mol Microbiol. 1995;18:715–27. 10.1111/j.1365-2958.1995.mmi_18040715.x. [Abstract] [CrossRef] [Google Scholar]
49. Winter SE, Winter MG, Godinez I, Yang H-J, Russmann H, Andrews-Polymenis HL, et al. A rapid change in virulence gene expression during the transition from the intestinal lumen into tissue promotes systemic dissemination of Salmonella. PLoS Pathog. 2010;6:e1001060. 10.1371/journal.ppat.1001060. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
50. Tran QT, Gomez G, Khare S, Lawhon SD, Raffatellu M, Baumler AJ, et al. The Salmonella enterica serotype Typhi Vi capsular antigen is expressed after the bacterium enters the ileal mucosa. Infect Immun. 2010;78:527–35. 10.1128/IAI.00972-09. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
51. Santander J, Wanda SY, Nickerson CA, Curtiss R., 3rd Role of RpoS in fine-tuning the synthesis of Vi capsular polysaccharide in Salmonella enterica serotype Typhi. Infect Immun. 2007;75:1382–92. 10.1128/IAI.00888-06. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
52. Khan AQ, Zhao L, Hirose K, Miyake M, Li T, Hashimoto Y, et al. Salmonella typhi rpoS mutant is less cytotoxic than the parent strain but survives inside resting THP-1 macrophages. FEMS Microbiol Lett. 1998;161:201–8. 10.1111/j.1574-6968.1998.tb12949.x. [Abstract] [CrossRef] [Google Scholar]
53. Wilson RP, Winter SE, Spees AM, Winter MG, Nishimori JH, Sanchez JF, et al. The Vi capsular polysaccharide prevents complement receptor 3-mediated clearance of Salmonella enterica serotype Typhi. Infect Immun. 2011;79:830–7. 10.1128/IAI.00961-10. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
54. Looney RJ, Steigbigel RT. Role of the Vi antigen of Salmonella typhi in resistance to host defense in vitro. J Lab Clin Med. 1986;108:506–16. [Abstract] [Google Scholar]
55. Heyns K, Kiessling G. Strukturaufklarung des Vi-antigens aus Citrobacter freundii (E. coli) 5396/38. Carbohydr Res. 1967;3:340–53. 10.1016/S0008-6215(00)82210-7. [CrossRef] [Google Scholar]
56. Haas PJ, van Strijp J. Anaphylatoxins: their role in bacterial infection and inflammation. Immunol Res. 2007;37:161–75. 10.1007/BF02697367. [Abstract] [CrossRef] [Google Scholar]
57. Hirose K, Ezaki T, Miyake M, Li T, Khan AQ, Kawamura Y, et al. Survival of Vi-capsulated and Vi-deleted Salmonella typhi strains in cultured macrophage expressing different levels of CD14 antigen. FEMS Microbiol Lett. 1997;147:259–65. 10.1111/j.1574-6968.1997.tb10251.x. [Abstract] [CrossRef] [Google Scholar]
58. Raffatellu M, Chessa D, Wilson RP, Dusold R, Rubino S, Baumler AJ. The Vi capsular antigen of Salmonella enterica serotype Typhi reduces Toll-like receptor-dependent interleukin-8 expression in the intestinal mucosa. Infect Immun. 2005;73:3367–74. 10.1128/IAI.73.6.3367-3374.2005. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
59. Wilson RP, Raffatellu M, Chessa D, Winter SE, Tukel C, Baumler AJ. The Vi-capsule prevents Toll-like receptor 4 recognition of Salmonella. Cell Microbiol. 2008;10:876–90. 10.1111/j.1462-5822.2007.01090.x. [Abstract] [CrossRef] [Google Scholar]
60. Jansen AM, Hall LJ, Clare S, Goulding D, Holt KE, Grant AJ, et al. A Salmonella Typhimurium-Typhi genomic chimera: a model to study Vi polysaccharide capsule function in vivo. PLoS Pathog. 2011;7:e1002131. 10.1371/journal.ppat.1002131. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
61. Haneda T, Winter SE, Butler BP, Wilson RP, Tukel C, Winter MG, et al. The capsule-encoding viaB locus reduces intestinal inflammation by a Salmonella pathogenicity island 1-independent mechanism. Infect Immun. 2009;77:2932–42. 10.1128/IAI.00172-09. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
62. Raffatellu M, Santos RL, Chessa D, Wilson RP, Winter SE, Rossetti CA, et al. The capsule encoding the viaB locus reduces interleukin-17 expression and mucosal innate responses in the bovine intestinal mucosa during infection with Salmonella enterica serotype Typhi. Infect Immun. 2007;75:4342–50. 10.1128/IAI.01571-06. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
63. Kossack RE, Guerrant RL, Densen P, Schadelin J, Mandell GL. Diminished neutrophil oxidative metabolism after phagocytosis of virulent Salmonella typhi. Infect Immun. 1981;31:674–8. [Europe PMC free article] [Abstract] [Google Scholar]
64. Miller RM, Garbus J, Schwartz AR, DuPont HL, Levine MM, Clyde DF, et al. A modified leukocyte nitroblue tetrazolium test in acute bacterial infection. Am J Clin Pathol. 1976;66:905–10. [Abstract] [Google Scholar]
65. Miller RM, Garbus J, Hornick RB. Lack of enhanced oxygen consumption by polymorphonuclear leukocytes on phagocytosis of virulent Salmonella typhi. Science. 1972;175:1010–1. 10.1126/science.175.4025.1010. [Abstract] [CrossRef] [Google Scholar]

Articles from Gut Microbes are provided here courtesy of Taylor & Francis

Citations & impact 


Impact metrics

Jump to Citations

Citations of article over time

Smart citations by scite.ai
Smart citations by scite.ai include citation statements extracted from the full text of the citing article. The number of the statements may be higher than the number of citations provided by EuropePMC if one paper cites another multiple times or lower if scite has not yet processed some of the citing articles.
Explore citation contexts and check if this article has been supported or disputed.
https://scite.ai/reports/10.4161/gmic.18602

Supporting
Mentioning
Contrasting
0
22
0

Article citations


Go to all (26) article citations

Similar Articles 


Funding 


Funders who supported this work.

NIAID NIH HHS (11)